While various biomarkers are detected, including the ovarian cancer biomarker HE4 and surface proteins on prostate cancer cells (PSMA), and pH change detection is demonstrated in ovarian cancer xenografts, this review specifies different detection levels for various analytes rather than a singular limit for a specific cancer type. This evidence concerns the gene FOLH1 and Familial prostate cancer.